These ASX blue-chip shares could rise 25%+ in 2024

Analysts are tipping big returns from these blue chips this year.

| More on:
A man with a yellow background makes an annoncement, indicating share price changes on the ASX

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX 200 index is home to a good number of quality blue-chip shares with strong business models and positive long-term growth outlooks.

But which ASX blue-chip shares could generate strong returns over the next 12 months?

Two that analysts are tipping as buys with big return potential are listed below. Here's what they are saying about them:

ResMed Inc (ASX: RMD)

Goldman Sachs believes that the ResMed sell-off has created a compelling buying opportunity for investors.

It recently retained its buy rating with a $32 price target, which suggests a potential upside of 26% for investors over the next 12 months. Its analysts see asymmetric upside risk at current levels. They explain:

[W]e believe the perceived downside risk from GLP-1/GIPs has been over-capitalised at RMD's current valuation. Overall, we reduce our TP -3% (with our earnings upgrades offset by mark to market multiples today), and continue to see asymmetric upside risk from current levels and reiterate our Buy rating.

Treasury Wine Estates Ltd (ASX: TWE)

Another blue chip ASX share that could generate big returns for investors is wine giant Treasury Wine.

Morgans currently has an add rating and a $14.15 price target on its shares, which implies a potential upside of over 30% for investors over the next 12 months.

The broker was happy with its recent US acquisition and believes it will be a boost to its margins. It said:

It may take some time for the market to digest TWE's acquisition of Paso Robles luxury wine business, DAOU Vineyards (DAOU) for US$900m (A$1.4bn) given it required a large capital raising. The acquisition is in line with TWE's premiumisation and growth strategy and will strengthen a key gap in Treasury Americas (TA) portfolio. Importantly, DAOU has generated solid earnings growth and is a high margin business. It consequently allowed TWE to upgrade its margins targets. While not without risk given the size of this transaction, if TWE delivers on its investment case, there is material upside to our valuation.

In addition, Morgans highlights that the ASX blue-chip share could be given a major lift if China removes its tariffs. It adds:

The key near term share price catalyst is if China removes the tariffs on Australian wine imports.

Motley Fool contributor James Mickleboro has positions in ResMed and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Blue Chip Shares

3 Australian shares with bullish catalysts heading into 2026

Not all ASX shares are equal in 2026. These three have catalysts that could move the needle.

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Blue Chip Shares

Where to invest $10,000 into ASX 200 shares in January 2026

Brokers think these shares are top picks for investors next month.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Blue Chip Shares

2 ASX giants to buy and hold for the next 20 years

Looking for the best shares to buy and hold? Here are two blue chips to consider.

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today
Blue Chip Shares

The ASX blue chip shares I'd buy during the next correction

In the share market, it can pay to hope for the best but prepare for the worst.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Blue Chip Shares

Is now the time to buy Wesfarmers shares?

Wesfarmers shares have traded sideways recently. Is this a buying opportunity or simply fair value?

Read more »

A group of six young people doing the limbo on a beach, indicating oversold shares that can not go any lower.
Share Fallers

Down over 40% this year, could these 3 ASX shares bounce back in 2026?

After a brutal 2025, these 3 ASX shares have been heavily sold off and could be worth watching for a…

Read more »

Excited couple celebrating success while looking at smartphone.
Blue Chip Shares

3 no-brainer ASX 200 shares to buy with $5,000

You don't need a brain to see that these shares could be quality investments.

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Blue Chip Shares

BHP, Macquarie, and Westpac: Naughty or nice? 3 popular ASX shares examined

Let's see if these blue chips made their shareholders smile in 2025.

Read more »